AU1697788A - Outer membrane protein f of pseudomonas aeruginosa - Google Patents

Outer membrane protein f of pseudomonas aeruginosa

Info

Publication number
AU1697788A
AU1697788A AU16977/88A AU1697788A AU1697788A AU 1697788 A AU1697788 A AU 1697788A AU 16977/88 A AU16977/88 A AU 16977/88A AU 1697788 A AU1697788 A AU 1697788A AU 1697788 A AU1697788 A AU 1697788A
Authority
AU
Australia
Prior art keywords
pseudomonas aeruginosa
membrane protein
outer membrane
ompf
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU16977/88A
Other versions
AU617318B2 (en
Inventor
Horst Domdey
Michael Duchene
Friedrich Lottspeich
Bernd-Ulrich Von Specht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU1697788A publication Critical patent/AU1697788A/en
Application granted granted Critical
Publication of AU617318B2 publication Critical patent/AU617318B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

The gene for outer membrane protein F (OMPF) of Pseudomonas aeruginosa has been isolated, sequenced and expressed to produce OMPF and immunogenic part-sequences in the amount and purity necessary for use for the preparation of vaccines.
AU16977/88A 1987-06-03 1988-06-02 Outer membrane protein f of pseudomonas aeruginosa Ceased AU617318B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3718591 1987-06-03
DE19873718591 DE3718591A1 (en) 1987-06-03 1987-06-03 AEUSSERES MEMBRANE PROTEIN F BY PSEUDOMONAS AERUGINOSA

Publications (2)

Publication Number Publication Date
AU1697788A true AU1697788A (en) 1988-12-08
AU617318B2 AU617318B2 (en) 1991-11-28

Family

ID=6328966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16977/88A Ceased AU617318B2 (en) 1987-06-03 1988-06-02 Outer membrane protein f of pseudomonas aeruginosa

Country Status (7)

Country Link
EP (1) EP0297291B1 (en)
JP (5) JPS6485086A (en)
AT (1) ATE95564T1 (en)
AU (1) AU617318B2 (en)
CA (1) CA1341015C (en)
DE (2) DE3718591A1 (en)
ES (1) ES2059436T3 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8900670A (en) * 1989-03-17 1990-10-16 Stichting Tech Wetenschapp POLYNUCLEOTIDE PROBE, METHOD AND KIT FOR IDENTIFYING AND DETECTING GRAM-NEGATIVE BACTERIA.
WO1993024636A1 (en) * 1992-05-29 1993-12-09 The University Of British Columbia Use of protein oprf for bacterial cell surface expression of oligopeptides
US6001564A (en) * 1994-09-12 1999-12-14 Infectio Diagnostic, Inc. Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
ATE190657T1 (en) * 1994-12-16 2000-04-15 Chiron Behring Gmbh & Co IMMUNOGENIC HYBRID PROTEIN OPRF-OPRL AVAILABLE FROM MEMBRANE PROTEINS OF PSEUDOMONAS AERUGINOSA
US5994066A (en) * 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
KR100461710B1 (en) * 1997-09-13 2005-09-28 씨제이 주식회사 Novel Pseudomonas aeruginosa cell membrane protein gene and vaccine for preventing Pseudomonas aeruginosa infection using the same
GB9915044D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
JP2003511015A (en) 1999-09-28 2003-03-25 インフェクティオ ダイアグノスティク（アイ．ディー．アイ．）インコーポレイティド Generating highly conserved genes, as well as species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers, algae, archaea, bacteria, fungi from diagnostic clinical specimens And their use for rapid detection and identification of parasite microorganisms
JP4481646B2 (en) * 2001-11-13 2010-06-16 アイディー バイオメディカル コーポレーション Pseudomonas aeruginosa polypeptide
EP1790659B1 (en) 2001-11-13 2013-07-31 ID Biomedical Corporation Polypeptides of pseudomonas aeruginosa
ES2826555T3 (en) 2012-11-30 2021-05-18 Glaxosmithkline Biologicals Sa Pseudomonas antigens and antigen combination
EP4116316A1 (en) 2015-07-04 2023-01-11 Evaxion Biotech A/S Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
WO2018127545A1 (en) 2017-01-05 2018-07-12 Evaxion Biotech Aps Vaccines targeting pseudomonas aeruginosa

Also Published As

Publication number Publication date
JP2000074922A (en) 2000-03-14
EP0297291A2 (en) 1989-01-04
AU617318B2 (en) 1991-11-28
DE3884680D1 (en) 1993-11-11
ATE95564T1 (en) 1993-10-15
EP0297291A3 (en) 1989-03-29
DE3718591A1 (en) 1988-12-15
JP2003289889A (en) 2003-10-14
JPS6485086A (en) 1989-03-30
ES2059436T3 (en) 1994-11-16
JP2002165593A (en) 2002-06-11
EP0297291B1 (en) 1993-10-06
JP2006187286A (en) 2006-07-20
CA1341015C (en) 2000-06-06

Similar Documents

Publication Publication Date Title
AU617318B2 (en) Outer membrane protein f of pseudomonas aeruginosa
AU567257B2 (en) Sucralfat-suspension
EP1013284A3 (en) Purified forms of dnase
AU1170588A (en) Methods and deoxyribonucleic acid for the preparation of tissue factor protein
AU1331588A (en) Method for treatment of alcohol abuse
HK14294A (en) Skin improving composition containing gamma-linolenic acid or dihomo-gamma-linolenic acid
IL78337A (en) Relatively pure rubber polymerase,process for its preparation and its use for the preparation of natural rubber
AU7073087A (en) Thiolactam-N-acetic acid derivatives, their production and use
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
WO1996034964A3 (en) Stable variant hk2 polypeptide
AU3927189A (en) N-2,3-butadienyl tri- and tetraaminoalkane derivatives
EP0338410A3 (en) Escherichia coli secretor mutants
WO1991015512A3 (en) Hiv envelope polypeptides
MY103362A (en) Production of proteins in active forms
ES2004099A6 (en) Use of biologically active polypeptides and compositions containing them.
AU2458988A (en) The preparation, by genetic manipulation, of anticoagulative protein pp4
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU4016089A (en) The expression of homologous and heterologous proteins, which are able to function, on the outer membrane of e. coli and other gram-negative bacteria
WO1987001698A3 (en) 1,4-naphthalenediol and 1,4-hydroquinone derivatives
DE3279949D1 (en) Novel microorganisms of the genus eschericia, hybrid dna for use in their production and the use of the microorganisms in the preparation of glutathione
AU7633987A (en) The use of 15-deoxyspergualine as a pharmaceutical
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
AU1880988A (en) Anilino iminoazoles and iminoazines, process for their preparation and their use as herbicides
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
EP0367302A3 (en) Process for semi-synthesis of human insulin, water-soluble cross-linked achromobacter protease i for use therein and a process for preparing the same